RNGE RANGE IMPACT, INC. Insider Trading

10% owner LoConti bought 2,333,333 shares of RNGE at $0.15 for $349,999.95 on 2025-09-23, raising stake 13.9%.

LoConti, a 10% owner, deployed approximately $350.0K to acquire 2,333,333 shares at $0.15, increasing his holding from 16,797,146 to 19,130,479 shares. The purchase occurs as the stock trades at $0.16 current price, down -50.0% from its 52-week high of $0.32 but up +3.2% over 30 days. Notably, his prior three buys at RNGE exhibited a 3-of-4 well-timed pattern at the 90-day mark, with two prior purchases yielding +22.8% and +55.2% returns; his cross-ticker track record spans 9 prior buys with an 87.50% 90-day win rate and +17.5% average 90-day return. The timing context is material: the company reported annual revenue decline of -53.4%, negative full-year net income, and latest quarterly revenue of $1,391,482.00 with net loss of $798,181.00, placing fundamental support in question. A cluster pattern is also present: two other insiders bought within the past 14 days, suggesting coordinated conviction despite deteriorating business metrics.

Director Feighan buys 666,667 shares at $0.15; holds 3.73M post-trade amid company's -53.4% revenue decline and unprofitability.

Director Edward F. Feighan purchased 666,667 shares at $0.15 on 2025-09-23, increasing his holdings to 3,732,356 shares (+21.7% from pre-transaction level). This represents a significant position increase at a stock price that is -50.0% from its 52-week high of $0.32. The purchase occurs amid deteriorating fundamentals: the company reported annual revenue decline of -53.4%, posted a net loss of $-798,181.00 in the latest quarter, and remains unprofitable on a full-year basis with a $17.4M market cap. Notably, his single prior trade at RNGE (a buy on 2023-12-21) achieved a 90-day return of +126.7%, demonstrating strong timing on his previous entry at this ticker. A cluster pattern is also present—2 other insiders bought within the past 14 days—which may reflect coordinated confidence or responses to a specific corporate catalyst. The timing and magnitude of this purchase warrant observation against the company's weak operational trajectory.

CEO Michael Cavanaugh buys 666,667 shares of RNGE at $0.15; holds 2.55M shares (+35.5%). Cluster pattern: 2 other insiders also bought in past 14 days.

CEO Michael Cavanaugh purchased 666,667 shares at $0.15 on 2025-09-23, increasing his holdings by 35.5% to 2.55M shares, with total investment value of $100,000.05. His prior purchase at RNGE on 2023-12-21 realized a 90-day return of +126.7%, demonstrating well-timed entry in the same stock previously. The current stock trades at $0.16, down 50.0% from its 52-week high of $0.32, while the company reported negative net income of $-798,181.00 in the latest quarter and revenue decline of -53.4% year-over-year. The transaction occurs as part of a broader cluster pattern in which 2 other insiders also bought within the past 14 days, suggesting coordinated conviction during a period of significant operational and valuation pressure.

10% Owner LoConti purchases 113,000 shares in 2 transactions at $0.13–$0.16, stock currently at $0.23.

LoConti, a 10% owner, executed 2 separate purchases totaling 113,000 shares for $18,328.00 ($18.3K) at a blended average price of $0.16 on 2025-04-07. At the current price of $0.23, these shares reflect a post-transaction gain, though this represents near-term appreciation rather than evidence of predictive timing. His cross-ticker track record shows 7 prior buys with a 90d win rate of 83.33%, but his same-ticker history at RNGE is mixed: 1 of 2 prior buys at this ticker was well-timed at the 90-day mark. The company remains unprofitable with net income of $-4,920,338.00 ($-4.9M) in the latest quarter and annual revenue declining -53.4% year-over-year. While the transaction is modest in dollar terms ($18.3K) and adds only 2.3% to his existing 4,847,377-share holdings, the combination of accumulated insider ownership (now 4,960,377 shares post-transaction), mixed timing outcomes on prior RNGE trades, and deteriorating company fundamentals warrants monitoring of the underlying business trajectory rather than viewing this as a strong conviction signal.

10% owner LoConti Joseph E. buys 5,000 RNGE shares at $0.20 on 2025-01-28; stock down 61.0% from 52-week high and -11.1% over 30 days.

LoConti, a 10% owner, purchased 5,000 shares at $0.20 on 2025-01-28 for $1,000.00, extending his holdings to 4,847,377 shares. The purchase occurs while RANGE IMPACT trades at $0.16, representing a -61.0% decline from its 52-week high of $0.41 and a -11.1% drop over the past 30 days, suggesting the trade took place near the peak of a recent sell-off. The company is deeply unprofitable, reporting a net loss of $4,920,338.00 against quarterly revenue of $2,171,655.00, though it shows strong top-line momentum with annual revenue growth of +300.4%. Across his cross-ticker open-market history, LoConti's prior 6 buys averaged +14.5% returns over 30 days and +20.5% over 90 days with a 100.00% win rate, but he has one prior trade at RNGE—a buy on 2025-01-21—which is still within its 90-day evaluation window. The significance is moderate: while insider buying at a major shareholder level during a steep decline warrants attention, the company's severe losses, stock's recent momentum deterioration, and the limited same-ticker track record (only one prior trade with outcome not yet measurable) prevent a higher rating.

10% owner LoConti bought 3,333,333 shares of RNGE at $0.15 (500.0K), raising stake to 16,797,146 shares (+24.8%)

LoConti Joseph E., a 10% owner, deployed $499,999.95 in a discrete open-market purchase of 3,333,333 shares at $0.15 on 2025-01-21, expanding his holdings by 24.8% to 16,797,146 shares post-transaction. This is the first insider transaction in a period of rapid fundamental growth—annual revenue expanded 300.4% year-over-year to $2,171,655.00 in the latest quarter—though the company is currently unprofitable with net income of $-4,920,338.00. Across his open-market history on all tickers, LoConti maintains a 100.00% 90-day win rate with average 90-day returns of +20.5% from prior buys, a track record that may inform interpretation of conviction. The stock currently trades at $0.18, down 22.8% over 90 days and 57.1% from its 52-week high of $0.42, providing context on valuation depth at the time of purchase.